Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Grade IV GBM Patients
Status:
Unknown status
Trial end date:
2021-04-30
Target enrollment:
Participant gender:
Summary
The purpose of phase II/III study: Determining the Overall Survival（OS）of Chlorogenic acid
for injection comparing to in the advanced Glioblastoma Patients through study completion（an
average of 18 months）after the first dose of chlorogenic acid for injection and Lomustine.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd